Search Results 311-320 of 15939 for SC

  1. A Study to Evaluate the Effectiveness and Safety of Triple Combination Therapy in High Risk Crohn's Disease (CD) - Mayo Clinic

    ... [SC]), and an immunomodulator (oral methotrexate) on endoscopic remission in participants with newly-diagnosed Crohn's Disease (CD) stratified at higher risk ...

  2. Publications - Ryan J. Solinsky, M.D. - Mayo Clinic

    2019. Solinsky R, Donovan JM, Kirshblum SC. Charcot Spine following chronic spinal cord injury: an analysis of 201 published cases. Spinal Cord. 2019 ...

  3. Publications - Niti R. Aggarwal, M.D. - Mayo Clinic

    ... SC, Sweitzer B, Talbot AW, Vallabhajosyula S, Whittle J, Williams KA Sr, Writing Committee Members. 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline ...

  4. Publications - Basar Sareyyupoglu, M.D. - Mayo Clinic

    Mitchell SC, Vinnakota A, Deo SV, Markowitz AH, Sareyyupoglu B, Elgudin Y, Medalion B, Tzagournis A, Sabik J, Park SJ. Relationship between intraoperative ...

  5. Publications - Wolfgang Singer, M.D. - Mayo Clinic

    Is EE, Ciftci Inceoglu S, Tekin SC, Albayrak B, Sonsoz MR, Kuran B, Singer W. Validation and reliability of the Turkish version of the composite autonomic ...

  6. Translating COVID-19 facts for diverse community members - Mayo Clinic News Network

    ... Sc., who together with Mark Wieland, M.D., M.P.H. leads a community engaged research partnership and uses a community-based participatory research approach ...

  7. Publications - Mayra Guerrero, M.D. - Mayo Clinic

    Malaisrie SC, Zajarias A, Leon MB, Mack MJ, Pibarot P, Hahn RT, Brown D, Wong SC, Oldemeyer JB, Shang K, Leipsic J, Blanke P, Guerrero M. Transcatheter ...

  8. A Study of the Effectiveness and Safety of Vedolizumab Compared to Adalimumab for Participants with Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of vedolizumab intravenous (IV) treatment compared to adalimumab subcutaneous (SC) ...

  9. Plasma Cell Disorders Clinical Trials - Mayo Clinic Research

    The primary objective of this study is to determine whether treatment with daratumumab administered subcutaneously (SC) prolongs progression-free survival ...

  10. Eddie L. Greene, M.D. - Doctors and Medical Staff - Mayo Clinic

    ... South Carolina. 1999 - 2000. FellowSouthern Society for Clinical ... MemberDiabetes Initiative of South Carolina, Medical University of South Carolina.